Pancreatic Cell News Volume 13.32 | Aug 16 2022

    0
    32








    2022-08-16 | PACN 13.32


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 13.32 – 16 August, 2022
    TOP STORY

    The Transcription Factor E2F1 Controls the GLP-1 Receptor Pathway in Pancreatic β Cells

    Researchers reported that that β cell-specific genetic ablation of E2f1 impaired glucose homeostasis associated with decreased expression of the Glp-1 receptor (Glp1r) in E2f1β−/− pancreatic islets.
    [Cell Reports]

    Full ArticleGraphical Abstract
    Try proven workflows for your hPSC culture. Click to request your offer now.
    PUBLICATIONSRanked by the impact factor of the journal

    MiR-190 Ameliorates Glucotoxicity-Induced Dysfunction and Apoptosis of Pancreatic β-Cells by Inhibiting NOX2-Mediated Reactive Oxygen Species Production

    Scientists identified miR-190 as a candidate regulator that could effectively restore insulin expression in NIT-1 cells under high-glucose stimulation.
    [Peerj]

    Full Article

    Lutein Inhibits IL-6 Expression by Inducing PPAR-γ Activation and SOCS3 Expression in Cerulein-Stimulated Pancreatic Acinar Cells

    Investigators reported that cerulein increased phospho‑specific forms of JAK2 and STAT3, and mRNA and protein expression of IL‑6, but decreased cytokine signaling 3 (SOCS3) levels in AR42J cells.
    [Molecular Medicine Reports]

    Abstract

    Loss of FGFR4 Promotes the Malignant Phenotype of PDAC

    Scientists reported that increased proliferation of FGFR4-depleted PDAC cells correlated with hyperactivation of the mTORC1 pathway both in vitro and in vivo.
    [Oncogene]

    Full Article

    CDK7 Inhibition Augments Response to Multidrug Chemotherapy in Pancreatic Cancer

    Using gene knockout and pharmacological inhibition of cyclin-dependent kinase 7 (CDK7) by THZ1, the authors reported cell cycle arrest, apoptosis induction, and DNA damage through the STAT3-MCL1-CHK1 axis.
    [Journal of Experimental & Clinical Cancer Research]

    Full Article

    Therapeutic Potential of a Water-Soluble Silver-Diclofenac Coordination Polymer on 3D Pancreatic Cancer Spheroids

    A 3D model representing human pancreas/duct carcinoma and human lung adenocarcinoma was designed and applied as a clear proof of the remarkable therapeutic potential of a new coordination polymer n·3nH2O.
    [Journal of Medicinal Chemistry]

    AbstractGraphical Abstract

    N6-Methyladenosine-Mediated CELF2 Regulates CD44 Alternative Splicing Affecting Tumorigenesis via ERAD Pathway in Pancreatic Cancer

    Using in vivo and in vitro experiments, the authors demonstrated that abnormal expression of (CUGBP) Elav-like family member 2 (CELF2) affected the stemness, apoptosis, and proliferation of pancreatic cancer cells.
    [Cell and Bioscience]

    Full Article

    ID1 Marks the Tumorigenesis of Pancreatic Ductal Adenocarcinoma in Mouse and Human

    Using Ingenuity Pathway Analysis analysis on the differentially expressed genes, researchers determined that EIF2 signaling was the core pathway regulating the development of PDAC.
    [Scientific Reports]

    Full Article

    Design and Synthesis of Novel Pipernonaline Derivatives As Anti-Austerity Agents Against Human Pancreatic Cancer PANC-1 Cells

    Investigators demonstrated that pipernonaline, one of the components of the spice pepper, preferentially reduced the survival of human pancreatic cancer PANC-1 cells under nutrient-deprived conditions.
    [Bioorganic & Medicinal Chemistry]

    Full ArticleGraphical Abstract
    New human primary cancer-sourced blood products, immune cell subsets, and more. Click to view products.
    REVIEWS

    Every Islet Matters: Improving the Impact of Human Islet Research

    The authors overview the status of the field of human islet research, highlight the challenges and propose actions that could accelerate research progress and increase understanding of type 2 diabetes to slow its pandemic spreading.
    [Nature Metabolism]

    Abstract
    INDUSTRY AND POLICY NEWS

    UNC, NC A&T Receive $4M from NIH to Increase Diversity in Nutrition, Obesity and Diabetes Research

    The National Institute of Diabetes and Digestive and Kidney Disease, part of the National Institutes of Health (NIH), has awarded $4 million to support career advancement for nutrition, obesity and diabetes researchers from underrepresented groups.
    [UNC Gillings School Of Global Public Health]

    Press Release
    FEATURED EVENT

    EASL NAFLD Summit 2022

    September 15 – September 17, 2022
    Dublin, Ireland, United Kingdom

    > See All Events

    JOB OPPORTUNITIES

    Senior Investigator – Cancer Research

    NIH National Cancer Institute – Bethesda, Maryland, United States

    Research Project Coordinator – Biology

    Dalla Lana School of Public Health – Toronto, Ontario, Canada

    Postdoctoral Fellow – Lymphangiogenesis in Pancreatic Diseases

    Northwestern University – Chicago, Illinois, United States

    Postdoctoral Scientist – Systems Oncology Group

    CRUK Manchester Institute – Manchester, United Kingdom

    Research Project Advisor – Regenerative Medicine Institute

    Cedars-Sinai – Los Angeles, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pancreatic Cell News Twitter